Among these prognostic genes or genomes, MYCN amplification (MNA), associated with rapid disease progression in patients of all ages and stages, is the most characterized and unfavorable prognostic biomarker of NB [4, 11, 12]. This evidence concerns the gene MYCN and neuroblastoma.